Corcept Therapeutics Stock News & Updates

[WKN: 529882 | Symbol: CORT]

TOP-5 Price Targets of Analysts on May 13, 2026

Siemens Energy [DE000ENER6Y0] JPMorgan reiterates Overweight rating and raises the price target from...

Corcept Therapeutics: FDA Approval as a Gamechanger - Oncology Breakthrough as a Price Driver

FDA Approval as a Historic Milestone For Corcept Therapeutics (CORT) , late March 2026 marks a pivotal...

Corcept Therapeutics in our Pivotal Point Check: Breakthrough in Cancer Research - ROSELLA Study Success Catapults Stock up Over 100%!

Ovarian cancer is the fifth leading cause of cancer-related death among women. The ROSELLA study...

Stocks in Action USA: Garmin, Rocket and Corcept.

Garmin (GRMN) - The wearable specialist focuses on AI in the fitness sector: New subscription platform...

Darvas Screening: DraftKings, Carvana, Corcept Therapeutics, Innodata

DraftKings DraftKings (NASDAQ: DKNG) is a digital sports entertainment and gaming company that offers...

Corcept Therapeutics: Rising Company in the Treatment of Cushing's Syndrome

Corcept Therapeutics is a specialist in cortisol modulation and controls the excess production of the...

Corcept Therapeutics (CORT): Canaccord sees 111% price potential - Phase III data from the ROSELLA study could impress

Corcept Therapeutics Inc. (CORT) is focused on the development of drugs that modulate the effects of...

TOP-5 Price Targets of Analysts on January 30, 2025

Secunet Security Networks [DE0007276503]: Warburg Research reaffirms Buy rating and raises price target...

Corcept Therapeutics: Stress in the Fight Against Stress Hormones

Hope Bearer Against Stress Hormones : With Korlym and Relacorilant, Corcept aims to regulate the stress...